Insufficient scRNA-seq data for expression of CYP2D7 at single-cell level.
Insufficient scRNA-seq data for expression of CYP2D7 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
liver | 100% | 5298.43 | 226 / 226 | 87% | 11.98 | 352 / 406 |
esophagus | 98% | 161.64 | 1415 / 1445 | 75% | 1.54 | 138 / 183 |
brain | 98% | 253.03 | 2579 / 2642 | 72% | 1.93 | 505 / 705 |
intestine | 99% | 173.23 | 953 / 966 | 60% | 1.46 | 315 / 527 |
uterus | 98% | 187.45 | 166 / 170 | 60% | 1.29 | 276 / 459 |
thymus | 100% | 398.77 | 653 / 653 | 58% | 1.19 | 348 / 605 |
stomach | 97% | 123.27 | 350 / 359 | 56% | 1.41 | 160 / 286 |
bladder | 100% | 169.62 | 21 / 21 | 53% | 1.10 | 267 / 504 |
ovary | 100% | 184.23 | 180 / 180 | 51% | 0.97 | 220 / 430 |
lung | 100% | 203.40 | 576 / 578 | 49% | 1.18 | 570 / 1155 |
pancreas | 97% | 111.43 | 317 / 328 | 48% | 0.90 | 85 / 178 |
kidney | 100% | 294.54 | 89 / 89 | 40% | 0.79 | 364 / 901 |
prostate | 100% | 334.78 | 244 / 245 | 35% | 0.55 | 176 / 502 |
adrenal gland | 98% | 136.34 | 254 / 258 | 28% | 0.55 | 64 / 230 |
skin | 91% | 188.82 | 1639 / 1809 | 29% | 0.53 | 136 / 472 |
breast | 100% | 202.17 | 459 / 459 | 18% | 0.30 | 203 / 1118 |
spleen | 100% | 282.69 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 1.16 | 1 / 1 |
adipose | 99% | 147.03 | 1190 / 1204 | 0% | 0 | 0 / 0 |
peripheral blood | 94% | 137.19 | 877 / 929 | 0% | 0 | 0 / 0 |
blood vessel | 92% | 91.98 | 1232 / 1335 | 0% | 0 | 0 / 0 |
heart | 63% | 44.24 | 544 / 861 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 49% | 0.82 | 22 / 45 |
lymph node | 0% | 0 | 0 / 0 | 28% | 0.42 | 8 / 29 |
muscle | 16% | 9.10 | 126 / 803 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 15% | 0.20 | 12 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0042178 | Biological process | xenobiotic catabolic process |
GO_0006805 | Biological process | xenobiotic metabolic process |
GO_0019369 | Biological process | arachidonic acid metabolic process |
GO_0043231 | Cellular component | intracellular membrane-bounded organelle |
GO_0016020 | Cellular component | membrane |
GO_0005737 | Cellular component | cytoplasm |
GO_0005739 | Cellular component | mitochondrion |
GO_0005506 | Molecular function | iron ion binding |
GO_0020037 | Molecular function | heme binding |
GO_0070330 | Molecular function | aromatase activity |
GO_0016712 | Molecular function | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen |
Gene name | CYP2D7 |
Protein name | Cytochrome P450 (EC 1.14.14.-) Cytochrome P450 family 2 subfamily D member 7 (gene/pseudogene) (Putative cytochrome P450 2D7) Putative cytochrome P450 2D7 Putative cytochrome P450 2D7 (EC 1.14.14.1) |
Synonyms | |
Description | FUNCTION: May be responsible for the metabolism of many drugs and environmental chemicals that it oxidizes. It may be involved in the metabolism of codeine to morphine . However, another study could not confirm it . . FUNCTION: Cytochromes P450 are a group of heme-thiolate monooxygenases. In liver microsomes, this enzyme is involved in an NADPH-dependent electron transport pathway. It oxidizes a variety of structurally unrelated compounds, including steroids, fatty acids, and xenobiotics. . |
Accessions | ENST00000635668.1 F5H6E7 ENST00000635135.1 A0A087X1C5 A0A0U1RRC6 ENST00000435101.1 A0A0U1RQD0 ENST00000634782.1 ENST00000618719.2 |